GRIN2D and Alzheimer disease: In a genome-wide association study of Alzheimer's disease, it was found that the expression of the brain messenger glutamate receptor Grin2d was reduced, potentially leading to impaired synaptic function, which is crucial for communication between nerve cells in the brain [62].